These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30315622)

  • 21. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant Reduction of Central-Line Associated Bloodstream Infections in a Network of Diverse Neonatal Nurseries.
    Shepherd EG; Kelly TJ; Vinsel JA; Cunningham DJ; Keels E; Beauseau W; McClead RE
    J Pediatr; 2015 Jul; 167(1):41-6.e1-3. PubMed ID: 25917770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding Gram-negative Central Line-Associated Blood Stream Infection in a Surgical Trauma ICU.
    Duane TM; Kikhia RM; Wolfe LG; Ober J; Tessier JM
    Am Surg; 2015 Aug; 81(8):816-9. PubMed ID: 26215246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India.
    Singhal T; Shah S; Thakkar P; Naik R
    Indian J Med Microbiol; 2019; 37(4):521-526. PubMed ID: 32436874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience.
    Chang AK; Foca MD; Jin Z; Vasudev R; Laird M; Schwartz S; Qureshi M; Kolb M; Levinson A; Bhatia M; Kung A; Garvin J; George D; Della-Latta P; Whittier S; Saiman L; Satwani P
    Am J Infect Control; 2016 Dec; 44(12):1650-1655. PubMed ID: 27378008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009-2013.
    Lin WP; Chang YC; Wu UI; Hung MC; Chuang PY; Wang JT; Sheng WH; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):644-651. PubMed ID: 28888825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact and cost-effectiveness of split-septum and single-use prefilled flushing device vs 3-way stopcock on central line-associated bloodstream infection rates in India: a randomized clinical trial conducted by the International Nosocomial Infection Control Consortium (INICC).
    Rosenthal VD; Udwadia FE; Kumar S; Poojary A; Sankar R; Orellano PW; Durgad S; Thulasiraman M; Bahirune S; Kumbhar S; Patil P
    Am J Infect Control; 2015 Oct; 43(10):1040-5. PubMed ID: 26164769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
    Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
    Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of tunneled central venous catheter associated blood stream infections in children.
    Nourian MM; Schwartz AL; Stevens A; Scaife ER; Bucher BT
    J Pediatr Surg; 2018 Sep; 53(9):1839-1842. PubMed ID: 29397962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey.
    Son CH; Daniels TL; Eagan JA; Edmond MB; Fishman NO; Fraser TG; Kamboj M; Maragakis LL; Mehta SA; Perl TM; Phillips MS; Price CS; Talbot TR; Wilson SJ; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):869-74. PubMed ID: 22869259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.
    Rinke ML; Bundy DG; Milstone AM; Deuber K; Chen AR; Colantuoni E; Miller MR
    Jt Comm J Qual Patient Saf; 2013 Aug; 39(8):361-70. PubMed ID: 23991509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Central Venous Catheter-Associated Bloodstream Infection in Pediatric Patients: A Cohort Study.
    Carter JH; Langley JM; Kuhle S; Kirkland S
    Infect Control Hosp Epidemiol; 2016 Aug; 37(8):939-945. PubMed ID: 27139311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
    Linder LA; Gerdy C; Jo Y; Wilson A
    J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line-associated bloodstream infection definition.
    Kovacs CS; Fatica C; Butler R; Gordon SM; Fraser TG
    Am J Infect Control; 2016 Nov; 44(11):1252-1255. PubMed ID: 27158091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
    Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
    Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of central line-associated bloodstream infection in an intensive care unit].
    Espiau M; Pujol M; Campins-Martí M; Planes AM; Peña Y; Balcells J; Roqueta J
    An Pediatr (Barc); 2011 Sep; 75(3):188-93. PubMed ID: 21507738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals.
    Gozu A; Clay C; Younus F
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):619-22. PubMed ID: 21558777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.